Physician

Adam Glassman, M.D.

According to 2025 Medicare claims, Adam Glassman, M.D. (NPI: 1710046800) practices pulmonary disease in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is HOLY NAME PULMONARY ASSOCIATES, PC (NPI: 1144484866; TIN: 830511119) and primary practice location at 07666-4245. Glassman is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Glassman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 454 traditional Medicare patients, billed 1,172 HCPCS/CPT codes, and received $119,098 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 744 prescription claims across 126 beneficiaries totaling $263,670 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,917 claims. Open Payments data shows 49 records totaling $527. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $221,846 to $119,098. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	774	2,844	$221,846
2016	791	2,655	$207,610
2017	754	2,438	$196,396
2018	693	2,398	$193,768
2019	573	1,760	$145,097
2020	558	1,650	$153,809
2021	531	1,580	$160,531
2022	530	1,506	$152,866
2023	525	1,363	$131,606
2024	454	1,172	$119,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	148	851	$178,365
2016	159	944	$200,425
2017	158	956	$240,374
2018	151	948	$248,339
2019	162	903	$250,000
2020	127	748	$236,177
2021	119	776	$255,693
2022	122	787	$266,415
2023	133	740	$315,137
2024	126	744	$263,670

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	729	1,731	$55,801
2016	761	1,910	$54,616
2017	794	1,931	$56,834
2018	1,080	2,366	$79,993
2019	912	2,061	$86,732
2020	803	2,005	$79,315
2021	740	1,781	$74,982
2022	765	1,807	$58,066
2023	754	1,836	$63,874
2024	856	1,917	$72,241

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	75	151	$183
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	50	59	$152
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	212	$105
95810	Sleep study in sleep lab (6 years or older)	59	59	$102
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	158	429	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	120	4,920	$102,028
Breo Ellipta	Fluticasone/Vilanterol	73	2,970	$38,222
Eliquis	Apixaban	18	540	$10,624
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	450	$9,311
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	570	$8,278

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	84	189	$8,875
A7031	Face mask interface, replacement for full face mask, each	N	38	103	$8,341
A7030	Full face mask used with positive airway pressure device, each	N	47	110	$8,130
A7032	Cushion for use on nasal mask interface, replacement only, each	N	43	89	$7,733
E0601	Continuous positive airway pressure (cpap) device	Y	53	265	$7,696

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$527	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Glassman, M.D.?

Tedicare shows public-source Medicare data for Adam Glassman, M.D. (NPI 1710046800), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Glassman, M.D. have ACO affiliation data?

Adam Glassman, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Adam Glassman, M.D.?

Adam Glassman, M.D. is linked to HOLY NAME PULMONARY ASSOCIATES, PC (billing NPI 1144484866) in the available physician profile data.

Does Adam Glassman, M.D. have Open Payments data?

Adam Glassman, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.